Virpax Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Changes in Control of Registrant, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits